Literature DB >> 8995689

Persistent poliovirus infection in mouse motoneurons.

J Destombes1, T Couderc, D Thiesson, S Girard, S G Wilt, B Blondel.   

Abstract

Poliovirus (PV) is the causal agent of paralytic poliomyelitis. Many survivors of the acute disease, after decades of clinical stability, develop new muscular symptoms called postpolio syndrome. It has been hypothesized that the persistence of PV in the spinal cord is involved in the etiology of this syndrome. To investigate the ability of PV to persist in the spinal cord after the onset of paralysis, we exploited a mouse model in which most animals inoculated with a mouse-adapted mutant survived after the onset of paralysis. Light microscopy and ultrastructural immunohistochemical studies and reverse transcription followed by nested PCR performed on spinal cord from paralyzed mice demonstrated that PV persisted in the mouse spinal cord for at least 12 months after the onset of paralysis. This mouse model provides a new tool for studying poliomyelitis evolution after the onset of paralysis.

Entities:  

Mesh:

Year:  1997        PMID: 8995689      PMCID: PMC191220     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Emerging concept of poliomyelitis infection.

Authors:  D BODIAN
Journal:  Science       Date:  1955-07-15       Impact factor: 47.728

2.  Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus.

Authors:  T C Wong; M Ayata; S Ueda; A Hirano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Molecular pathogenesis of neural lesions induced by poliovirus type 1.

Authors:  T Couderc; C Christodoulou; H Kopecka; S Marsden; L F Taffs; R Crainic; F Horaud
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

5.  Late motor neuron degeneration following poliomyelitis.

Authors:  A M Campbell; E R Williams; J Pearce
Journal:  Neurology       Date:  1969-11       Impact factor: 9.910

6.  Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis.

Authors:  P Muir; F Nicholson; M K Sharief; E J Thompson; N J Cairns; P Lantos; G T Spencer; H J Kaminski; J E Banatvala
Journal:  Ann N Y Acad Sci       Date:  1995-05-25       Impact factor: 5.691

7.  Transgenic mice susceptible to poliovirus.

Authors:  S Koike; C Taya; T Kurata; S Abe; I Ise; H Yonekawa; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

8.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA.

Authors:  C Adami; J Pooley; J Glomb; E Stecker; F Fazal; J O Fleming; S C Baker
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections.

Authors:  R Cattaneo; A Schmid; D Eschle; K Baczko; V ter Meulen; M A Billeter
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

View more
  10 in total

1.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread.

Authors:  Elizabeth A Caine; Jorge E Osorio
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Poliovirus induces apoptosis in the mouse central nervous system.

Authors:  S Girard; T Couderc; J Destombes; D Thiesson; F Delpeyroux; B Blondel
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets.

Authors:  Mayara F Maggioli; Maureen H V Fernandes; Lok R Joshi; Bishwas Sharma; Megan M Tweet; Jessica C G Noll; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

5.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

6.  Why does viral RNA sometimes persist after recovery from acute infections?

Authors:  Diane E Griffin
Journal:  PLoS Biol       Date:  2022-06-01       Impact factor: 9.593

Review 7.  Persistent Enterovirus Infection: Little Deletions, Long Infections.

Authors:  Nora M Chapman
Journal:  Vaccines (Basel)       Date:  2022-05-12

8.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

Review 9.  Environmental insults: critical triggers for amyotrophic lateral sclerosis.

Authors:  Bing Yu; Roger Pamphlett
Journal:  Transl Neurodegener       Date:  2017-06-16       Impact factor: 8.014

Review 10.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.